Technology News, IT News, and Press release service Submit Press Release

Information Tech News & Press Release Distribution

Press release distribution service

Home | Search Global IT News:
IT News & Press Release Distribution:

Immunosuppressants Drugs Market – Global Industry Perspective, Comprehensive Analysis and Forecast, 2021 – 2028

(IT-NEWSWIRE.COM, October 13, 2021 )



Market Overview

Immunosuppressant drugs are a class of drugs that suppress, or reduce, the strength of the bodys immune system. During organ transplantation, from a donor to a recipient, the immune system of the recipient gets stimulated and thus, produces an immune response like it does in response to other foreign material.



This immune response causes serious damage to the transplanted or grafted organ. It is often called rejection, which can be acute or chronic. This organ rejection is prohibited by using immunosuppressive drugs, which block the immune response and protect the new organ and its function.



View full report: https://bit.ly/3FGILgf



Market Dynamics

The global immunosuppressants drugs market growth is driven by innovations and advancements in organ transplantation procedures. The rise in the volume of these procedures is driving the growth of the market in the forecast period.



The increasing prevalence of diabetes is expected to drive the growth in the forecast period



An immunosuppressant is an agent that can suppress or prevent the immune response. Immunosuppressants drugs are used to prevent rejection of a transplanted organ and to treat autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, psoriasis/psoriatic arthritis, multiple sclerosis, systemic lupus erythematosus (SLE), inflammatory bowel disease, Addisons disease, and graves' disease among others. Commonly used immunosuppressants drugs include tacrolimus, cyclosporine A, glucocorticoids, methotrexate, and rituximab.



According to the 2017 report of the International Diabetes Federation (IDF), approximately 425 million adults (20-79 years) were suffering from diabetes, and by 2045 this number may rise to 629 million, globally.



Several government organizations and NGOs are working to increase awareness about the socioeconomic impact of autoimmunity through fostering and facilitating collaboration in the areas of education, public awareness, research, and patient services in an effective, ethical, and efficient manner. This factor will drive the growth of the market in the forecast period.



Market Segmentation:

By Drug Class

Calcineurin Inhibitors

Antiproliferative Agents

mTOR Inhibitor

By Indication

Organ Transplantation

Autoimmune Disorders

Non-Autoimmune Inflammatory Diseases

By Distribution Channel

Hospital Pharmacy

Pharmacy Stores



Download free sample: https://bit.ly/3iWThGk



Geographical Analysis

North America region holds the largest market share global immunosuppressants drugs market



North America is expected to hold a major market share in the global immunosuppressant drugs market due to the increasing prevalence of autoimmune diseases and the rapid rise in the number of organ transplants in this region.



According to the Centers for Disease Control (CDC), in the year 2017, it was estimated that approximately 19 percent of men and 25 percent of women in the United States had doctor-diagnosed arthritis, in addition, doctor-diagnosed arthritis was prevalent in 16.4 percent of people who were underweight, while 27.7 percent of individuals who were obese.



Furthermore, technological advancements in tissue engineering and organ transplantations, increasing healthcare spending coupled with increasing investments in research and development, and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.



Drug classes such as CETP inhibitors have been withdrawn or discontinued even in the later stages of trials due to adverse effects or failure to achieve satisfactory results. Risks associated with immunosuppressants pose a major challenge to their entry into the market.



Competitive Landscape

The immunosuppressants drugs market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Astellas Pharma, Inc, Sanofi (Genzyme), Bristol-Myers Squibb Company, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc, GlaxoSmithKline Plc, Allergan Plc, Accord Healthcare Ltd, and Mylan Laboratories, Inc. among others.



The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the immunosuppressants drugs market globally.



Related Topic's

Autoimmune Treatment Market, Allergy Immunotherapies Market, Thrombocytopenia Management Market, Systemic Lupus Erythematosus Market, Systemic Sclerosis Market

DataM Intelligence

Sai Kiran

+1 877 441 4866

pr@datamintelligence.com

Source: EmailWire.Com

Source: EmailWire.com

Information Technology Resources
  • Application Software
  • Bioinformatics
  • Computers
  • Computer Games
  • Enterprise Software
  • Graphics/Printing/CAD
  • Hardware/Peripheral
  • industrial Computers
  • Information
  • Internet
  • Multimedia
  • Networking
  • Public Sector
  • Robotics
  • Semiconductor
  • Software
  • Telecommunications
  • Webmaster
  • Information Technology (IT) Advertisement
    Information Technology Sponsors



    Information Technology Publications
    We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Information Technology resource center today to browse our selection of 600+ complimentary Information Technology magazines, white papers, webinars, podcasts, and more. Get popular titles including:

    The Integration Journey—a Field Guide to Enterprise Integration for SOA
    Government Technology\'s Public CIO
    Protecting Content During Business Disruption: Are You Covered?

    No credit cards, coupons, or promo codes required. Try it today!

    Press release distribution service

    ITPresswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

    :: Home: :: Submit Press Release :: Subscribe to News :: Shop Online :: Contact Us :: Help

    For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com.
    Copyright 2008 GroupWeb Media LLC
    GroupWeb Media Network

    Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
    | i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
    ITPresswire.com - Newswire and Press Release service of GroupWeb Media LLC